Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Berlin

Showing results (181-190 of 248) with videos related to

Pageof 25
Sort By:
Research Communications in Chemical Pathology and Pharmacology|October 1, 1992
Effects of BRB-I-28, a novel antiarrhythmic agent, and its derivatives on cardiac Na+,K(+)-ATPase, Mg(2+)-ATPase activities and contractile forceC L Chen, S Sangiah, E Patterson, et al.
Journal of Medicinal Chemistry|January 1, 1991
Novel heteroarotinoids: synthesis and biological activityL W Spruce, J B Gale, K D Berlin, et al.
American Journal of Clinical Oncology|January 11, 2011
Dual blockade of the EGFR and COX-2 pathways: a phase II trial of cetuximab and celecoxib in patients with chemotherapy refractory metastatic colorectal cancerEmily Chan, Bonnie Lafleur, Mace L Rothenberg, et al.
Molecules (Basel, Switzerland)|November 11, 2022
Novel Complexes of 3-[3-(1<i>H</i>-Imidazol-1-yl)propyl]-3,7-diaza-bispidines and β-Cyclodextrin as Coatings to Protect and Stimulate Sprouting Wheat SeedsAltynay B Kaldybayeva, Valentina K Yu, Aigul E Malmakova, et al.
Investigational New Drugs|July 30, 1999
A phase I study of gemcitabine, 5-fluorouracil and leucovorin in patients with advanced, recurrent, and/or metastatic solid tumorsJ D Berlin, D B Alberti, R Z Arzoomanian, et al.
Journal of Cardiovascular Pharmacology|August 1, 1996
Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heartT Fazekas, L Carlsson, B J Scherlag, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2020
Phase I Study of Trifluridine/Tipiracil Plus Irinotecan and Bevacizumab in Advanced Gastrointestinal TumorsAnna M Varghese, Dana B Cardin, Jonathan Hersch, et al.
Investigational New Drugs|May 9, 2008
Phase I trial of pemetrexed plus oxaliplatin administered every other week in patients with metastatic cancerDaniel G Stover, A Craig Lockhart, Jordan D Berlin, et al.
Journal of Pharmaceutical Sciences|May 1, 1993
Synthesis of potential metabolites of ethyl (E)-4-[2-(3,4-dihydro-4,4-dimethyl-2H-1-benzopyran-6-yl)-1-propenyl] benzoateP S Sunthankar, K D Berlin, E C Nelson, et al.
Journal of Medicinal Chemistry|June 1, 1977
Synthesis and biological activity of some derivatives of thiochroman-4-one and tetrahydrothiapyran-4-oneK Ramalingam, G X Thyvelikakath, K D Berlin, et al.
Pageof 25

Showing results (181-190 of 248) with videos related to

Sort By:
Pageof 25
Research Communications in Chemical Pathology and Pharmacology|October 1, 1992
Effects of BRB-I-28, a novel antiarrhythmic agent, and its derivatives on cardiac Na+,K(+)-ATPase, Mg(2+)-ATPase activities and contractile forceC L Chen, S Sangiah, E Patterson, et al.
Journal of Medicinal Chemistry|January 1, 1991
Novel heteroarotinoids: synthesis and biological activityL W Spruce, J B Gale, K D Berlin, et al.
American Journal of Clinical Oncology|January 11, 2011
Dual blockade of the EGFR and COX-2 pathways: a phase II trial of cetuximab and celecoxib in patients with chemotherapy refractory metastatic colorectal cancerEmily Chan, Bonnie Lafleur, Mace L Rothenberg, et al.
Molecules (Basel, Switzerland)|November 11, 2022
Novel Complexes of 3-[3-(1<i>H</i>-Imidazol-1-yl)propyl]-3,7-diaza-bispidines and β-Cyclodextrin as Coatings to Protect and Stimulate Sprouting Wheat SeedsAltynay B Kaldybayeva, Valentina K Yu, Aigul E Malmakova, et al.
Investigational New Drugs|July 30, 1999
A phase I study of gemcitabine, 5-fluorouracil and leucovorin in patients with advanced, recurrent, and/or metastatic solid tumorsJ D Berlin, D B Alberti, R Z Arzoomanian, et al.
Journal of Cardiovascular Pharmacology|August 1, 1996
Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heartT Fazekas, L Carlsson, B J Scherlag, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2020
Phase I Study of Trifluridine/Tipiracil Plus Irinotecan and Bevacizumab in Advanced Gastrointestinal TumorsAnna M Varghese, Dana B Cardin, Jonathan Hersch, et al.
Investigational New Drugs|May 9, 2008
Phase I trial of pemetrexed plus oxaliplatin administered every other week in patients with metastatic cancerDaniel G Stover, A Craig Lockhart, Jordan D Berlin, et al.
Journal of Pharmaceutical Sciences|May 1, 1993
Synthesis of potential metabolites of ethyl (E)-4-[2-(3,4-dihydro-4,4-dimethyl-2H-1-benzopyran-6-yl)-1-propenyl] benzoateP S Sunthankar, K D Berlin, E C Nelson, et al.
Journal of Medicinal Chemistry|June 1, 1977
Synthesis and biological activity of some derivatives of thiochroman-4-one and tetrahydrothiapyran-4-oneK Ramalingam, G X Thyvelikakath, K D Berlin, et al.
Pageof 25